Purpose: to issue task A04 base task order award, "evaluation of therapeutics and vaccines in mouse models of dengue virus"

Ended Awarded Last action

Contract number
HHSN27200006
Awardee
Awarding agency
Obligated
$1,998,664

Award facts

Opportunity
  • NIHAI2016059 Solicitation number
Contract value 100% obligated
$1,998,663.67 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Galveston, TX 77555, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 · To DE-obligate funds in the amount of $689,894.43. -$689,894
Funding Only Action P00006 · To DE-obligate FY2018 funds in the amount of $91,235. -$91,236
Exercise an Option P00005 · To exercise quantity option 6A. $162,535
Exercise an Option P00004 · To exercise quantity option 4A. $154,111
Exercise an Option P00003 · To exercise quantity option 2 in the amount of $798,251, $798,251
Exercise an Option P00002 · The purpose of this modification is to: (1) extend the base completion date from april 30, 2019 to may 08, 2019 at no additional cost to the government; (2)… $789,448
Supplemental Agreement for work within scope P00001 · The purpose of this modification is to change attachment 1 - statement of work, at no additional cost to the government. $0
Original award $875,449

About this award

This is a delivery order award by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB) to conduct "Evaluation of Therapeutics and Vaccines in Mouse Models of Dengue Virus." The award is under NIAID's Preclinical Models of Infectious Diseases multiple-award contract, which provides preclinical research services related to infectious diseases. UTMB has extensive experience supporting federal agencies through research, clinical trials, and public health programs, particularly in the area of infectious disease. The potential value of this task order is $1,998,663.67, with a completion date of July 6, 2023. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract HHSN27200006?

HHSN27200006 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 26, 2017.

How much is contract HHSN27200006 worth?

The government has obligated $1,998,664 on HHSN27200006.

Is contract HHSN27200006 an order under another contract?

Yes. HHSN27200006 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.

Was contract HHSN27200006 competed?

The extent of competition for HHSN27200006 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award